Prestige Consumer Q3 2025 Earnings Report
Key Takeaways
Prestige Consumer Healthcare Inc. reported a 2.7% increase in revenue to $290.3 million and diluted EPS of $1.22, up approximately 15% year-over-year. The company raised its full-year fiscal 2025 earnings outlook, driven by strong free cash flow and debt reduction.
Revenue increased by 2.7% to $290.3 million in Q3 2025 compared to the prior year.
Diluted EPS increased approximately 15% to $1.22 in Q3 2025.
Leverage reduced to 2.5x in Q3 2025 due to strong profitability and cash flow.
Full-year fiscal 2025 earnings outlook raised.
Prestige Consumer
Prestige Consumer
Prestige Consumer Revenue by Segment
Forward Guidance
The company raised its earnings outlook for fiscal year 2025, anticipating approximately 1% organic revenue growth and adjusted diluted EPS of approximately $4.50, supported by strong free cash flows.
Positive Outlook
- Achieve fiscal 2025 outlook.
- Approximately 1% organic revenue growth.
- Lower interest expense.
- Reduced shares outstanding.
- Strong financial performance.
Challenges Ahead
- No specific negatives were mentioned in the provided text.
Revenue & Expenses
Visualization of income flow from segment revenue to net income